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Key Points: 
It is recognised by healthcare practitioners that adherence to long-term intraocular 
pressure (IOP) lowering medication is poor in patients with glaucoma, which is a 
significant factor in disease progression.   
 
A significant problem associated with adherence is the patient’s failure to recognise 
there is a need to administer their eye drops as prescribed.   
 
Ocular hypotensive drugs are prescribed to patients with Chronic Open Angle 
Glaucoma to minimise the visual field loss by slowing the progression rate of the 
disease in individuals with high intraocular pressures (IOPs) and so preserving their 
vision. 
 
There are three main techniques followed in assessing adherence. These are patient 
self-report, monitoring devices and renewing prescriptions.  
 
Key Words:  Adherence, compliance, persistence, concordance, intraocular 
pressure, glaucoma.   
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Adherence: Compliance, Persistence and Concordance in the Management of 
Glaucoma Part I 
 
Abstract 
 
Adherence is laden with difficulties in relation to the management of glaucoma.  
Perhaps a significant issue associated with a lack of the aforementioned is 
associated with the patient’s failure to recognise there is a need to administer their 
eye drops as prescribed.  Undoubtedly the greatest issue is that patients experience 
no pain with their debilitating eye disease.  It is not until there is considerable loss of 
vision that awareness of the need to administer eye drops becomes a reality.  
Understanding the complexities of adherence and its association with compliance, 
persistence and concordance as discussed in this article can assist the healthcare 
practitioner in developing models of care that help the patient in self-management of 
their glaucoma.  This article is published in two parts.  Part I addresses the 
background to issues associated with adherence in glaucoma management including 
definition of terms, assessing adherence and barriers and interventions to improve 
adherence. Part II addresses the Theory of Adherence and Self-Management of 
Chronic Open Angle Glaucoma (COAG).  It provides perspectives, theories and 
models that can be employed to improve adherence in the self-management of 
glaucoma. 
 
Introduction 
 
Adherence is a term that is frequently discussed by healthcare practitioners in 
relation to patients managing their health.  It is recognised by healthcare 
practitioners that adherence to long-term intraocular pressure (IOP) lowering 
medication, in particular, is poor in patients with glaucoma, which is a significant 
factor in disease progression.  The concept of adherence is recognised by 
healthcare practitioners as being laden with difficulties in relation to the management 
of glaucoma.  A significant problem associated with adherence is the patient’s failure 
to recognise there is a need to administer their eye drops as prescribed.  
Undoubtedly the greatest issue is that patients experience no pain with their 
debilitating eye disease (Amro et al, 2011).  It is not until there is considerable loss of 
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vision that awareness of the need to administer eye drops becomes a reality.  This 
article addresses the concept of adherence in association with compliance, 
persistence and concordance in the management of glaucoma.  It provides the 
background associated with adherence in chronic conditions, explains the concepts 
of adherence, compliance, persistence and concordance, describes various 
mechanisms for assessing the concepts and delineates barriers and interventions to 
improve adherence. 
  
Background: 
 
Patient adherence with medical treatments for chronic conditions is known to be far 
from ideal (Schwartz and Quigley, 2008). Approximately 9% of all prescriptions 
written across all therapeutic areas are never filled; especially at initial stage of 
treatment (Lash and Harding, 1995). The scope of this issue is enormous throughout 
chronic condition literature.  Diseases that are asymptomatic in nature like Chronic 
Open Angle Glaucoma (COAG) are more prone to poor adherence (Dimatteo et al, 
2002) with studies suggesting it could be as high as 80% (Olthoff et al, 2005).  
 
Ocular hypotensive drugs are prescribed to patients with COAG to minimise the 
visual field loss by slowing the progression rate of the disease in individuals with 
elevated intraocular pressures (IOPs) and so preserving their vision (Nordstrom et al, 
2005). It is important that these drops are administered regularly on a daily basis for 
life (Gray et al, 2009). Failing to do so, could result in additional risks and costs 
because of the need for more hospital appointments and diagnostic tests, having to 
switch to other medications and/or wastage of unfinished pharmaceutical supplies, 
and ultimately needing to advance to surgical intervention (Bissell et al, 2004; 
Hoevenaars et al, 2008; Gray et al, 2009).  It is important to note here that, 
according to some medical literature, medication such as Nitroglycerin may increase 
intraocular pressure and should be used with caution in patients that have glaucoma.  
However the effect of organic nitrates and nitrites on intraocular pressure has been found 
to be variable and that there is no evidence that these drugs cause narrow angle 
glaucoma (Drugs.Com, 2011)   
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The literature addressing glaucoma treatment adherence is vast, reflecting the 
variation in terminology used to describe it (such as compliance, persistence and 
concordance), its interventions and strategies designed to tackle poor adherence, 
barriers, and the way it is measured. Vermiere et al (2001) observed that during 
three decades of quantitative research into adherence ‘non-compliance’, more than 
200 variables have been studied.  However none can be considered as consistently 
predictive.  
 
Terminology 
 
The term adherence means to be consistent – to stick to a regimen.  Therefore from 
an ophthalmic (medical) perspective adherence means to stick to a prescription, and 
is viewed as a measure of whether eye drops have been instilled.  A lack of 
adherence refers to gaps in a therapy or treatment.   
 
Although the term ‘compliance’ has been used extensively in the medical model to 
refer to the extent to which patients’ behaviours’ correspond with providers’ 
recommendations (Schwartz, 2005) and implies their obedience to the doctor’s 
orders. Compliance views the patient as a passive recipient of instructions and 
directions of the superiorly experienced and knowledgeable doctor and reflects a 
paternalistic attitude. Unsurprisingly, this term has been abandoned for a more 
precise and less judgmental term, called adherence (Gray et al, 2009). Adherence in 
this sense is synonymous with compliance and has an association with 
concordance. Adherence was defined by (Lee et al, 2007) as consistency and 
accuracy with which a patient follows a recommended medical regimen. Compliance 
and adherence according to Britten (2001) have provided an ideological framework 
through which doctors can express their ideas about how patients ought to behave. 
This framework has justified blaming patients for not acting in accordance with 
doctors’ instructions and expectations. 
 
Mead and Bower (2002) highlighted the limitations of the compliance and adherence 
models in their application to health care relationships. The Independent Kings Fund 
report observed a “growing recognition” that the interests of those who provide 
health care do not necessarily coincide with the needs of those who use it. Where 
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interaction with patients based on this model is viewed as an opportunity to reinforce 
instructions and expectations, instead, Bissell et al (2004) have advocated for a 
more collaborative approach and open space where expertise of both patients and 
healthcare professionals can be pooled together to arrive at mutually agreed goals. 
In other words, healthcare professionals should seek to develop “concordance” with 
their patients attending the service (Working Party, 1997). Concordance was 
introduced in the 1997 by the Royal Pharmaceutical Society of Great Britain and 
intended to remove the implications of patient obedience or submissiveness to 
physician’s orders.   Notwithstanding, what is the association with persistence? 
 
Persistence is another term, not synonymous with compliance or adherence that is 
still in use as it refers to the length of time from commencement to discontinuation of 
a prescribed treatment (Reardon et al., 2004). Persistence can be considered to 
persevere such as in the continuous use of a medication. In this instance, the patient 
persists steadfastly in administering eye drops even though they sting and make the 
patient’s eyes red.  The terms adherence and persistence are similar and yet have 
differences.  For example, if a patient was prescribed a once-daily medication but 
actually takes the drug once every other day for an entire year; the patient would be 
50% adherent and 100% persistent.  Persistence leads on to a consideration of 
concordance.  
 
 
According to a multidisciplinary group of healthcare professionals, academics and 
members of the pharmaceutical industry in the UK, concordance, as a new approach 
to glaucoma treatment and professional-patient interaction, has been defined as: 
 
“Concordance is based on the notion that the work of the prescriber and patient in 
the consultation is a negotiation between equals and the aim is therefore a 
therapeutic alliance between them. This alliance, may, in the end, include an 
agreement to differ. Its strength lies in a new assumption of respect for the patient’s 
agenda and the creation of openness in the relationship, so that both doctor and 
patient together can proceed on the basis of reality and not of misunderstanding, 
distrust and concealment”  
 Working Party (1997:8).  
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The principles of concordance are not new (Britten, 2001).  The principles are 
increasingly referred to in health service research. In contrast to compliance and 
adherence, Williams and Calnan (1996) noted that concordance fits neatly with the 
political landscape of the NHS in the United Kingdom (UK) and is congruent with 
ideas such as shared clinical decision making, patient-centeredness and 
collaborative care (May and Mead, 1999). There are interesting studies that show 
the misunderstanding that arises between patients and doctors in the consultation 
around their treatment and the unvoiced patients’ agenda in this consultation 
(Williams and Calnan, 1996). Nonetheless, there is a need for more empirical 
research which can shed light on concordance relevant to patients with chronic 
conditions like COAG (Bissell et al, 2004). Regardless of the aforementioned, Justis 
(2010) has argued that the concordance approach has not been widely adopted.   
 
Assessing Adherence  
 
Assessing adherence accurately poses a significant challenge in glaucoma 
treatment (Schwartz and Quigley, 2008). Throughout the literature, there are three 
main techniques followed in measuring adherence. These are patient self-report, 
monitoring devices and renewing prescriptions.  
 
Patient Self-Report 
 
Using a numerical scale that allows patients to mark along the scale where they 
thought their answers should be without judgmental or leading questions is called 
patient self-report (Gray et al, 2009). Although simple and inexpensive, self-report 
whether by self-administered questionnaire or by interview, tends to overestimate 
adherence (Kass et al, 1986). Although this technique is subjective to recall bias and 
the desire to please health professionals, Gray et al (2009) observed that self-report 
is the most utilised method for assessing adherence in glaucoma. Schwartz and 
Quigley (2008) draw attention to the selection bias of patients who are willing to 
complete a questionnaire or agreed to be interviewed may demonstrate higher rates 
of adherence. Patients with poor adherence tend not to return for follow up and thus 
are unable to participate in a study.  
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Monitoring Devices  
 
In theory, an electronic monitoring device of dosing is considered the most reliable 
tool for assessment (Olthoff et al, 2005).  An example of such monitoring devices 
that have been used is the Medication Events Monitoring System (MEMS) (Sleath et 
al, 2011).  However, these devices cannot prove that a drop truly went in the 
patient’s eye or on the cheek, floor or in the sink (Schwartz and Quigley, 2008).  
These devices have advanced considerably in recent years where the device itself 
has become smaller and even invisible in some cases (Hermann and Diestelhorst, 
2006). However; it will be some time before more accurate and cost-effective 
devices are available for use (Gray et al, 2009).    
 
Renewing Prescriptions 
 
This method is an objective estimation of adherence and persistence by assessing 
patients’ continuity of the therapy (Schwartz and Quigley, 2008). Gray et al (2009) 
argue that this method provides an accurate estimation of persistence; however, 
obtaining a repeat prescription of a particular drug does not necessarily mean that 
the drug will be used as prescribed or used at all. 
 
Barriers and Interventions to Improve Adherence 
 
Determining barriers to adherence relies primarily on patients’ attitudes and thoughts 
which are well located in the merit of qualitative research (Lacey et al, 2009). Despite 
the call for further research relating to adherence with glaucoma therapy (Quigley et 
al, 2006) and the growing acceptance and use of qualitative methods in human 
behaviours (Green et al, 2002), there are few studies performed with in-depth 
qualitative perspectives (Taylor et al, 2002).  
 
Adherence issues are complex. Tsai et al (2003) reported as many as 71 unique 
situational obstacles on patients in the United States of America (USA). Following 
this observation, Tsai et al (2003) grouped the obstacles into four separate 
categories: situational/environmental factors (35 of 71; 49%), medication regimen 
 
 
9 
factors (23 of 71; 32%), patient factors (11 of 71, 16%), and provider factors (2 of 71; 
3%). For further details, refer to Table 1. The taxonomy formulated in this study 
could be useful in assisting healthcare professionals develop individualised 
interventions that optimise patient education and problem solving regarding their 
health care.  
 
Table 1: Categories of Barriers to Adherence 
Situational/environmental factors 
 
Accountability and lack of support 
Major life events 
Travel/away from home 
Competing activities 
Change in routine  
Treatment regimen 
 
Refill 
Cost of medication 
Complexity 
Change 
Side effects 
Patient Factors 
 
Knowledge/skills 
Memory 
Motivation/health beliefs 
Co-morbidity 
Providers factors 
 
Dissatisfaction 
Communication 
 
In another qualitative study Taylor et al (2002) explored poor adherence amongst 
glaucoma patients and revealed that forgetfulness was the main reason for poor 
adherence.  Other reasons were inability to instil eye drops even though the patients 
thought they could, treatment side effects, complexity of the treatment regimen, level 
of glaucoma knowledge and education, trying new treatment options and the cost of 
treatment. 
 
A more recent UK based study by Lacey et al (2009) revealed the following barriers: 
lack of knowledge and education, lack of faith in drop efficacy, problems with drop 
instilling, forgetting drops, practical problems (running out of drops, failing to reorder 
them, medication packaging, side effects and cost), age and individual differences 
(physical inability to instil drops, needing more assistance to instil drops, forgetting 
drops in the elderly population as compared to feeling depressed amongst the 
younger population as glaucoma is considered to be an elderly disorder).  
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Based on the above barriers, numerous studies have set out to improve treatment 
adherence in glaucoma patients by improving/removing one or more of the identified 
barriers. Broadly speaking, interventions that were designed to improve adherence 
comprised educational, drug comparison, and/or reminder devices.  
 
Educational and Individualised Care Planning 
 
These interventions are based on the belief that improving patients’ glaucoma 
knowledge and their understanding of the condition will eventually improve their 
adherence levels. Patients receive basic information on glaucoma and available 
treatment regimens and then helped to identify suitable times for instilling and storing 
their eye drops. Examples of this intervention are Norell (1979) and Sheppard et al 
(2003). Educational interventions refer to cognitive didactic approaches where 
behavioural principles such as reinforcement and feedback are increasingly used 
(Leventhal et al, 1997). To be effective, educational interventions have to be tailored 
to the patient’s particular needs, in addition to the quality of patient-provider 
interaction and the way information is passed (Van Dulmen et al, 2007). 
  
Drug Comparison (Technical Interventions) 
 
Most adherence interventions studies in this domain are aimed at simplification and 
reducing the number of doses per day or reducing the number of different drugs in 
the regimen (Van Dulmen et al, 2007). Other studies compared the adherence levels 
amongst patients prescribed two different drugs (Gray et al, 2009). Leventhal and 
Cameron (1987) argued that these technical solutions reflect the biomedical 
perspective of using medical expertise to find solutions for patients’ problems without 
engaging with patients.  
 
Reminder Devices (Behavioural Interventions) 
 
These interventions are based on the fact that forgetfulness is the main barrier to 
adherence and shares the assumption that reminding patients to take their eye drops 
will improve their adherence. There are different devices being used: a cap attached 
to the bottle that digitally displays the time and the day of the week the container was 
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last open and when was the last drop taken (Gray et al, 2009; Olthoff et al, 2005). 
Other studies have used a memory aid that provides an audible and visible reminder 
as to when a drop is due (Laster et al, 1996). In the USA, several studies have 
examined the use of incentives in which patients have been paid for taking their 
treatment. This intervention showed improvement in adherence levels in 10 out of 
the all trials reviewed (Giuffrida and Torgerson, 1997) and represents aspects of 
human behaviour theories where reminders can act as cues or stimuli and incentives 
as rewards.   
 
The three reviews did not demonstrate any convincing evidence to advocate a 
particular intervention over the others.  However, there have been reported 
significant yet small improvements in all interventions. Olthoff et al (2005) concluded 
that all the studies in his review lacked a thorough behavioural theory basis which is 
a conclusion shared by Van Dulmen et al (2007).  Van Dulmen et al (2007) indicated 
that further studies are needed to explore the theoretical components of these 
interventions. Furthermore, Gray et al (2009) did not find convincing evidence to 
recommend any particular intervention for improving adherence amongst glaucoma 
patients.  
 
Conclusion 
 
This article has addressed the concept of adherence in association with compliance, 
persistence and concordance in the management of glaucoma.  It has explained 
these concepts, described various mechanisms for assessing adherence and 
delineated barriers and interventions to improve adherence. Part II in this series will 
address the Theory of Adherence and Self-Management of Chronic Open Angle 
Glaucoma (COAG).  It will provide perspectives, theories and models that can be 
employed to improve adherence in the self-management of glaucoma. 
. 
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